Tentt

Lupin Completes VISUfarma Acquisition for Eye Care

Closed
HealthcareAdd-on

Deal Overview

Lupin has completed its acquisition of VISUfarma through a Netherlands subsidiary. The deal expands Lupin’s eye care portfolio to 60+ products.

The transaction is structured as an add-on within Lupin’s ophthalmology business, with VISUfarma’s product line integrated into Lupin’s existing portfolio.

Key Details

Transaction
Lupin acquires VISUfarma

Filed under

Source

Read full article on scanx.trade

via GN - completed acquisition of · April 1, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →